Eledon Pharmaceuticals, Inc. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Eledon Pharmaceuticals, Inc. (ELDN) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $0 as of 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2019-11-13
- 2019-09-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
- 2019-06-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
- 2019-03-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
- 2018-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-13 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-13 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 |
| 2017-12-31 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |